SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 434.86 millions for the March 2024 quarter as against Rs. 554.51 millions during the year-ago period.Net profit of the cmpany stood at Rs. 35.49 millions for the quarter ended March 2024 a decline of -36.65% from Rs. 56.02 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 51.56 millions from 79.96 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 434.86 554.51 -21.58 2087.02 2367.14 -11.83 2087.02 2367.14 -11.83
Other Income 24.87 25.59 -2.81 92.79 57.34 61.82 92.79 57.34 61.82
PBIDT 51.56 79.96 -35.52 323.46 398.85 -18.90 323.46 398.85 -18.90
Interest 2.17 1.96 10.71 8.14 4.13 97.09 8.14 4.13 97.09
PBDT 49.39 78.00 -36.68 315.32 360.13 -12.44 315.32 360.13 -12.44
Depreciation 4.03 4.79 -15.87 16.63 12.05 38.01 16.63 12.05 38.01
PBT 45.36 73.21 -38.04 298.69 348.08 -14.19 298.69 348.08 -14.19
TAX 9.87 17.19 -42.58 74.06 80.87 -8.42 74.06 80.87 -8.42
Deferred Tax -0.17 1.79 -109.50 -1.54 4.55 -133.85 -1.54 4.55 -133.85
PAT 35.49 56.02 -36.65 224.63 267.21 -15.94 224.63 267.21 -15.94
Equity 132.19 130.99 0.92 132.19 130.99 0.92 132.19 130.99 0.92
PBIDTM(%) 11.86 14.42 -17.78 15.50 16.85 -8.02 15.50 16.85 -8.02

Jagsonpal Pharma Share Price

192.80 -0.85 (-0.44%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×